Louis-based chemical company just pulled a batch of hand soap off shelves, and the official reason is boring enough to make you scroll past: bacterial contamination.
But if you've been paying attention to how consumer products actually get made in this country, the boring explanation is usually where the real story is hiding.
Intercon Chemical Company issued a recall affecting hand soap distributed across multiple states, citing possible contamination with Pseudomonas aeruginosa—a bacteria that's especially nasty for anyone with a compromised immune system, burns, or open wounds.
The FDA notice went out, a few local news stations ran a chyron, and most people moved on.
Here's what the recall notice doesn't lead with: this isn't some artisan soap shop in a converted garage.
Intercon is a contract manufacturer—the kind of company that makes the generic stuff slapped with store brands, hospital labels, and industrial supply logos you've never thought twice about.
When a contract manufacturer has a contamination issue, the question isn't just "which product?" It's "how many products share that same production line, that same water source, that same tank?" The Pseudomonas finding matters more than the headlines suggest.
This bacteria doesn't just float in from the air.
It thrives in water systems, in improperly cleaned equipment, in the kind of standing moisture that signals a facility's sanitation protocols have gaps.
A positive test in finished soap is often the last domino to fall, not the first.
Over the past several years, we've watched recalls cascade through eye drops, nasal sprays, artificial tears, and now hand soap—all categories where sterile manufacturing is supposedly non-negotiable.
Each time, regulators frame the incident as isolated.
Each time, the same structural weaknesses show up: aging plants, thin inspection budgets, and supply chains stretched so far that nobody at the brand level can name the factory that filled the bottle.
These aren't luxury buyers—they're institutions buying by the drum, often through distributors who switch suppliers based on price alone.
If a contaminated lot slips through, the people most exposed are the ones least able to absorb a hospital visit.
The FDA's recall database is public, but it's also a graveyard of quiet notices that never trend.
There's no central alert pushed to your phone when the soap in the dispenser by your kid's classroom sink gets flagged.
If you manage a facility, check your lot numbers against the recall notice directly—don't wait for a distributor email.
If you're a regular consumer, this particular recall likely doesn't touch your bathroom pump bottle, but it's a reminder that "antibacterial" on a label says nothing about what happened before the soap hit the plastic.
The deeper takeaway isn't that hand soap is dangerous.
It's that we've outsourced the safety of everyday products to a patchwork system of self-reporting and underfunded oversight, then act surprised when the patchwork frays.
Connect enough of them and you don't see isolated accidents—you see a pattern.
Our take: the most revealing part of this story isn't the bacteria they found.
It's how little anyone expects to learn about the facility, the water, or the other products that rolled off the same line.
Final Thoughts
Until that changes, keep reading the fine print—because nobody else is going to read it for you.